Arm vs. ASML: Which Semiconductor Stock Is a Better Buy in 2026?

ASML is favored over Arm for 2026, supported by its monopoly in EUV lithography and substantially lower valuation multiples: 39.2x forward P/E and 16.4x sales versus Arm at 139.3x and 64.3x, respectively. ASML generated $37.1B of FY2025 revenue (+15.6%), $10.9B of net income, and $12.1B of free cash flow, while Arm posted FY2026 revenue of $4.9B (+22.8%) and $904M of net income. Both benefit from AI-driven semiconductor demand, but ASML's equipment chokepoint is viewed as more defensible, despite exposure to chipmaker capex cycles and export restrictions.

Analysis

The cleaner expression of AI semiconductor scarcity is ASML rather than ARM: ASML monetizes each leading-edge capacity expansion at the highest-value manufacturing bottleneck, while ARM's economics depend on design wins translating into unit shipments and royalty mix upgrades. ARM's valuation leaves little tolerance for a slower smartphone replacement cycle, delayed server CPU share gains, or continued dilution from stock compensation; even solid execution can produce multiple compression if revenue growth merely normalizes. ASML's lower relative valuation provides a greater cushion, although its reported results will remain lumpy because customer tool acceptance and revenue recognition can shift across quarters.

Over the next 1-3 months, foundry capex commentary from TSMC, Samsung and Intel is the key read-through: confirmations of advanced-node and High-NA EUV deployment should support ASML bookings before revenue follows. The more non-obvious beneficiary is TSMC (TSM), whose access to scarce leading-edge lithography capacity reinforces pricing power versus Samsung and Intel Foundry; conversely, equipment names tied to broad wafer-fab spending such as LRCX and AMAT may not participate equally if spending concentrates in EUV-intensive leading nodes.

Consensus likely understates ASML's order-cycle volatility and overstates the immediacy of AI demand conversion into tool revenue. Export restrictions, a single large customer's capex deferral, or lower utilization at leading foundries could cause a sharp booking reset despite the monopoly. For ARM, the structural threat is not near-term displacement but a gradual RISC-V adoption curve in automotive, edge AI and Chinese silicon that weakens licensing leverage over 6-18 months.

Key Decisions for Investors

• Initiate a 6-12 month pair: long ASML / short ARM, sized beta-neutral. The trade captures ASML's more defensible cash conversion and lower expectation risk against ARM's premium multiple; reassess if ARM sustains accelerating royalty growth from data center and automotive sufficient to offset dilution.
• Add to ASML on any capex-driven drawdown rather than chase strength; use TSMC, Samsung and Intel forward capex guidance plus ASML net bookings as catalysts. Exit or reduce if two consecutive reporting periods show leading-edge customer deferrals or a material cut to annual shipment expectations.
• Maintain a watch-list long in TSM as a second-order beneficiary of constrained EUV capacity, funded against INTC if foundry execution remains delayed. The thesis is falsified by meaningful Samsung/Intel yield parity at advanced nodes or a broad AI-demand inventory correction.
• Avoid outright ARM longs until evidence shows data-center royalty mix and total royalty growth can remain elevated while SBC as a share of operating cash flow declines. A guidance raise without improvement in these quality-of-earnings indicators is not sufficient confirmation.